Satelia Cardio remote monitoring with therapeutic education reduced all-cause mortality by 40.1% (HR=0.599) in severe heart failure patients versus standard care.
Does a patient-centered remote monitoring device reduce all-cause mortality in heart failure patients with a previous hospitalization?
In a real-world cohort of severe heart failure patients, a patient-centered remote monitoring system significantly reduced all-cause mortality compared to standard of care.
Tasa de eventos absoluta: 0% vs 0%
Abstract Background and Aims Heart failure (HF) affects approximately 2% of the global population, with increasing incidence and a high risk of rehospitalization. This study focuses on a high-risk group defined as HF patients and at least one hospitalization in the previous 12 months, aiming to assess the impact of remote monitoring in this severe population. Objective To evaluate the "real life" national-scale impact of remote monitoring on all-cause mortality in HF patients, comparing those receiving Satelia® Cardio patient-centered remote monitoring intervention in addition to standard of care with those receiving standard of care alone. Methods A multicentric, real-world, propensity-weighted study was conducted using data from the French National Health Database (SNDS) between August 2018 and December 2022, covering more than 300 healthcare centers across France. Patients in the interventional group were referred to as the remote monitoring program (RMP) group. The therapeutic intervention consisted of remote monitoring of HF (symptoms and weight) using the Satelia Cardio solution and personalized therapeutic education based on follow-up outcomes via the medical device’s algorithm. The control group was referred to as the standard of care (SoC) group among the French HF population included in the national health database. The primary outcome was all-cause mortality, analyzed using the Kaplan-Meier method and compared between groups with an adjusted Cox regression model. Results After propensity weighting, 3,130 patients in the RMP group and 7,406 patients in the SoC group were included. Baseline characteristics were comparable between groups. In this severe population, with over 3,000 deaths recorded at 18 months, the Satelia Cardio remote monitoring intervention was associated with a significant reduction in all-cause mortality (HR=0,599, 95% CI 0.54-0.66; p 0.0001). Conclusions The main analysis demonstrates a dramatic positive impact of the HF patient-centered remote monitoring system (Satelia Cardio) with therapeutic education on reducing all-cause mortality compared to the SoC group in a real life study of severe heart failure patients.Association of RMP with all-cause mortal
Jourdain et al. (Sat,) reported a other. Satelia Cardio remote monitoring with therapeutic education reduced all-cause mortality by 40.1% (HR=0.599) in severe heart failure patients versus standard care.